Philips launches HealthSuite Clinical Trial Accelerator to help life science organizations run more flexible, patient-centric...
May 19 2020 - 4:00AM
Philips launches HealthSuite Clinical Trial Accelerator to help
life science organizations run more flexible, patient-centric
clinical trials
May 19, 2020
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced Clinical Trial Accelerator on Philips HealthSuite. This
new tailored set of capabilities allows life science organizations
to integrate, analyze and store clinical and patient-reported data
from multiple sources, providing actionable insights for better,
faster decision-making.
Philips HealthSuite is an integrated, modular set of
standards-based capabilities that support the development of
digital propositions across the health continuum, encompassing
HIPAA compliant, secure cloud capabilities. Clinical Trial
Accelerator enables patient-centric trials at home, managing the
collection of data while providing the security and compliance
expected from both patients and life science organizations.
Life science organizations face continued pressure to run more
efficient, cost-effective clinical trials. Empowering patients and
making it easier for them to stay connected and contribute to a
trial can have a significant impact on compliance rates and overall
success. At the same time, collecting data and identifying
actionable insights while ensuring the security and compliance of
patient information is key. Clinical Trial Accelerator is designed
to address these challenges, helping life science organizations
reach their goals faster and supporting greater flexibility in
trial design.
“Philips HealthSuite already provides cloud-based services and
tools to a wide array of healthcare organizations, and with
Clinical Trial Accelerator we have created a tailored set of
capabilities to support life science organizations,” said Dale
Wiggins, General Manager for the HealthSuite digital platform at
Philips. “Our innovative, flexible cloud platform leverages our
global healthcare capabilities and is supported by our compliance,
security and interoperability expertise.”
Tailored capabilities to accelerate clinical
trialsOther HealthSuite capabilities include an AI
Analytics Workbench for enhanced decision making and
standards-based interoperability for Digital Imaging and
Communication in Medicine (DICOM) data, as well as the HealthSuite
Clinical Data Lake, a new scalable micro-service that acts as a
centralized big data repository for high-volume clinical data
collection studies and includes controls to curate and manage data
in a manner that addresses regulatory requirements.
These HealthSuite capabilities offer companies cloud-based
services and technical tools that meet privacy, security and
regulatory requirements that they can use to develop and run a new
generation of connected healthcare applications. Unlike other
digital platforms, HealthSuite is purpose-built to solve the
complex challenges of healthcare, featuring capabilities to manage
device data, collect personal and health data, store and share data
securely, analyze data, build and deploy AI models, and create
solutions on the cloud.
In addition, these HealthSuite capabilities power a wide range
of both Philips and 3rd party connected healthcare applications in
areas including image-guided therapy, sleep and respiratory care,
ophthalmology, telehealth and self-medication. For 3rd party
collaborations, Philips is the provider of the relevant cloud-based
healthcare IT infrastructure and is not involved in the
commercialization of the products and services of these companies.
More information on Philips HealthSuite can be found at
www.philips.com/healthsuite.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel: +31 631 639 916Email:
mark.groves@philips.comTwitter: mark_groves
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Philips Care Orchestrator for sleep and respiratory
therapy
- Philips HealthSuite logo
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024